Skip to main content

Advertisement

SpringerLink
Log in

The sample size required for intervention studies on fracture prevention can be decreased by using a bone resorption marker in the inclusion criteria: prospective study of a subset of the Nagano Cohort, on behalf of the Adequate Treatment of Osteoporosis (A-TOP) Research Group

  • ORIGINAL ARTICLE
  • Published:
Journal of Bone and Mineral Metabolism Aims and scope Submit manuscript

Abstract

In drug developments for osteoporosis, large-scale and longterm fracture prevention studies have been required. We investigated whether or not it was possible to reduce the sample size and observation period under new selection criteria for an osteoporotic fracture-prevention study. A Poisson regression model was used to identify independent risks for incident vertebral fracture in 515 postmenopausal women who had had no intervention for osteoporosis; this group was a subset of Nagano Cohort participants. The total observation period for this group was 2577 person-years, and a total of 146 new vertebral fractures were observed. Risk assessment for incident vertebral fracture among numerical covariates revealed that the following items showed significant independent risks for incident fractures; namely, baseline age (hazard ratio [HR]; 1.84; 95% confidence interval (CI), 1.44–2.35; P < 0.001), number of preexisting vertebral fractures (HR, 1.28; 95% CI, 1.17–1.40; P < 0.001), baseline lumbar bone mineral density (LBMD) (HR, 0.79; 95% CI, 0.71–0.88; P < 0.001), and urinary excretion of deoxypyridinoline (DPD) (HR, 1.18; 95% CI, 1.03–1.35; P = 0.016). Because the initial urinary excretion of DPD was found to be a risk for incident vertebral fracture, in addition to the conventional risks, we assessed whether or not the sample size or observation period could be reduced by the incorporation of the urinary excretion of DPD into the selection criteria of a fracture-prevention study. The assessment of sample size was calculated, using the log rank test, at a two-tailed significance level of 5% and with a power of 80%. When osteoporotic patients with preexisting fracture were selected (conventional criteria), the 3-year probability of vertebral fracture was estimated as 14.3% in the present population. On the other hand, the new vertebral fracture rate during 3 years in the osteoporotic patients with preexisting fracture plus high urinary DPD (HR, above 1.0); (new selection criteria) was estimated as 23.2%. When the HR between test drug and placebo was changed from 0.4 to 0.8, the required sample size for any level of HR showed a 40% reduction for the new selection criteria compared to the conventional criteria. Therefore, the addition of urinary DPD level to the selection criteria is useful to reduce sample size in an osteoporosis fracture-prevention study.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. InstitutionalAuthorNameNIH Consensus Development Panel on Osteoporosis Prevention, Diagnosis, and Therapy (2001) ArticleTitleOsteoporosis prevention, diagnosis, and therapy JAMA 285 785–795 Occurrence Handle10.1001/jama.285.6.785

    Article  Google Scholar 

  2. SL Silverman ME Minshall W Shen KD Harper S Xie InstitutionalAuthorNameHealth-Related Quality of Life Subgroup of the Multiple Outcomes of Raloxifene Evaluation Study (2001) ArticleTitleThe relationship of health-related quality of life to prevalent and incident vertebral fractures in postmenopausal women with osteoporosis: results from Multiple Outcomes of Raloxifene Evaluation Study Arthritis Rheum 44 2611–2619 Occurrence Handle10.1002/1529-0131(200111)44:11<2611::AID-ART441>3.0.CO;2-N Occurrence Handle1:STN:280:DC%2BD3MnmsFeqsg%3D%3D Occurrence Handle11710717

    Article  CAS  PubMed  Google Scholar 

  3. A Oleksik P Lips A Dawson ME Minshall W Shen C Cooper J Kanis (2000) ArticleTitleHealth-related quality of life in postmenopausal women with low BMD with or without prevalent vertebral fractures J Bone Miner Res 15 1384–1392 Occurrence Handle1:STN:280:DC%2BD3M%2FhtF2jtg%3D%3D Occurrence Handle10893688

    CAS  PubMed  Google Scholar 

  4. JA Kanis EV McCloskey (1992) ArticleTitleEpidemiology of vertebral osteoporosis Bone 13 IssueIDSuppl 2 S1–10 Occurrence Handle1385718

    PubMed  Google Scholar 

  5. JR Center TV Nguyen D Schneider PN Sambrook JA Eisman (1999) ArticleTitleMortality after all major types of osteoporotic fracture in men and women: an observational study Lancet 353 878–882 Occurrence Handle10.1016/S0140-6736(98)09075-8 Occurrence Handle1:STN:280:DyaK1M7ptFOlug%3D%3D Occurrence Handle10093980

    Article  CAS  PubMed  Google Scholar 

  6. DM Kado WS Browner L Palermo MC Nevitt HK Genant SR Cummings (1999) ArticleTitleVertebral fractures and mortality in older women: a prospective study. Study of Osteoporotic Fractures Research Group Arch Intern Med 159 1215–1220 Occurrence Handle10.1001/archinte.159.11.1215 Occurrence Handle1:STN:280:DyaK1M3pslKguw%3D%3D Occurrence Handle10371229

    Article  CAS  PubMed  Google Scholar 

  7. DM Black SR Cummings DB Karpf JA Cauley DE Thompson MC Nevitt DC Bauer HK Genant WL Haskell R Marcus SM Ott JC Torner SA Quandt TF Reiss KE Ensrud (1996) ArticleTitleRandomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group Lancet 348 1535–1541 Occurrence Handle1:CAS:528:DyaK2sXisFCktQ%3D%3D Occurrence Handle8950879

    CAS  PubMed  Google Scholar 

  8. SR Cummings DM Black DE Thompson WB Applegate E Barrett-Connor TA Musliner L Palermo R Prineas SM Rubin JC Scott T Vogt R Wallace AJ Yates AZ LaCroix (1998) ArticleTitleEffect of alendronate on risk of fracture in women with low bone density but without vertebral fractures: results from the Fracture Intervention Trial JAMA 280 2077–2082 Occurrence Handle1:CAS:528:DyaK1MXjsVWruw%3D%3D Occurrence Handle9875874

    CAS  PubMed  Google Scholar 

  9. ST Harris NB Watts HK Genant CD McKeever T Hangartner M Keller CH Chesnut Suffix3rd J Brown EF Eriksen MS Hoseyni DW Axelrod PD Miller (1999) ArticleTitleEffects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial. Vertebral Efficacy with Risedronate Therapy (VERT) Study Group JAMA 282 1344–1352 Occurrence Handle10.1001/jama.282.14.1344 Occurrence Handle1:CAS:528:DyaK1MXmvFansr0%3D Occurrence Handle10527181

    Article  CAS  PubMed  Google Scholar 

  10. J Reginster HW Minne OH Sorensen M Hooper C Roux ML Brandi B Lund D Ethgen S Pack I Roumagnac R Eastell (2000) ArticleTitleRandomized trial of the effects of risedronate on vertebral fractures in women with established postmenopausal osteoporosis. Vertebral Efficacy with Risedronate Therapy (VERT) Study Group Osteoporosis Int 11 83–91 Occurrence Handle10.1007/s001980050010 Occurrence Handle1:CAS:528:DC%2BD3cXhvFGgsr0%3D

    Article  CAS  Google Scholar 

  11. B Ettinger DM Black BH Mitlak RK Knickerbocker T Nickelsen HK Genant C Christiansen PD Delmas JR Zanchetta J Stakkestad CC Gloer K Krueger FJ Cohen S Eckert KE Ensrud LV Avioli P Lips SR Cummings (1999) ArticleTitleReduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators JAMA 282 637–645 Occurrence Handle10.1001/jama.282.7.637 Occurrence Handle1:CAS:528:DyaK1MXlvVKqurg%3D Occurrence Handle10517716

    Article  CAS  PubMed  Google Scholar 

  12. PJ Meunier C Roux E Seeman S Ortolani JE Badurski TD Spector J Cannata A Balogh EM Lemmel S Pors-Nielsen R Rizzoli HK Genant JY Reginster (2004) ArticleTitleThe effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis N Engl J Med 350 459–468 Occurrence Handle10.1056/NEJMoa022436 Occurrence Handle1:CAS:528:DC%2BD2cXos1Snsw%3D%3D Occurrence Handle14749454

    Article  CAS  PubMed  Google Scholar 

  13. K Kushida M Shiraki T Nakamura H Kishimoto H Morii K Yamamoto K Kaneda M Fukunaga T Inoue M Nakashima H Orimo InstitutionalAuthorNameon behalf of the Alendronate/Alfacalcidol Fracture Intervention Study Group (2002) ArticleTitleThe efficacy of alendronate in reducing the risk for vertebral fracture in Japanese patients with osteoporosis: a randomized, double-blind, active-controlled, double-dummy trial Curr Ther Res Clin Exp 63 606–620 Occurrence Handle1:CAS:528:DC%2BD38XoslCnt70%3D

    CAS  Google Scholar 

  14. Director, Evaluation and Licensing Division, Pharmaceutical and Medical Safety Bureau, Ministry of Health and Welfare (1998) Guidelines Concerning Methods for Clinical Evaluation of Osteoporosis Drugs (Second Draft). Notification No 1010 of the Evaluation and Licensing Division, Pharmaceutical and Food Safety Bureau, dated November 2, 1998 (in Japanese). Japanese Minister of Health and Welfare, Tokyo

  15. ES Siris PD Miller E Barrett-Connor KG Faulkner LE Wehren TA Abbott ML Berger AC Santora LM Sherwood (2001) ArticleTitleIdentification and fracture outcomes of undiagnosed low bone mineral density in postmenopausal women: results from the National Osteoporosis Risk Assessment JAMA 286 2815–2822 Occurrence Handle10.1001/jama.286.22.2815 Occurrence Handle1:STN:280:DC%2BD3MjgtVGmug%3D%3D Occurrence Handle11735756

    Article  CAS  PubMed  Google Scholar 

  16. E Barrett-Connor ES Siris LE Wehren PD Miller TA Abbott ML Berger AC Santora LM Sherwood (2005) ArticleTitleOsteoporosis and fracture risk in women of different ethnic groups J Bone Miner Res 20 185–194 Occurrence Handle15647811

    PubMed  Google Scholar 

  17. HD Nelson M Helfand SH Woolf JD Allan (2002) ArticleTitleScreening for postmenopausal osteoporosis: a review of the evidence for the U.S. Preventive Services Task Force Ann Intern Med 137 529–541 Occurrence Handle12230356

    PubMed  Google Scholar 

  18. S Fujiwara F Kasagi N Masunari K Naito G Suzuki M Fukunaga (2003) ArticleTitleFracture prediction from bone mineral density in Japanese men and women J Bone Miner Res 18 1547–1553 Occurrence Handle12929946

    PubMed  Google Scholar 

  19. H Orimo Y Hayashi M Fukunaga T Sone S Fujiwara M Shiraki K Kushida S Miyamoto S Soen J Nishimura Y Oh-hashi T Hosoi I Gorai H Tanaka T Igai H Kishimoto InstitutionalAuthorNameOsteoporosis Diagnostic Criteria Review Committee: Japanese Society for Bone and Mineral Research (2001) ArticleTitleDiagnostic criteria for primary osteoporosis: year 2000 revision J Bone miner Metab 19 331–337 Occurrence Handle10.1007/s007740170001 Occurrence Handle1:STN:280:DC%2BD3MngvFGntw%3D%3D Occurrence Handle11685647

    Article  CAS  PubMed  Google Scholar 

  20. M Shiraki Y Shiraki C Aoki T Hosoi S Inoue M Kaneki Y Ouchi (1997) ArticleTitleAssociation of bone Mineral density with apolipoprotein E phenotype J Bone Miner Res 12 1438–1445 Occurrence Handle1:CAS:528:DyaK2sXmt1WksLo%3D Occurrence Handle9286760

    CAS  PubMed  Google Scholar 

  21. HK Genant M Jergas L Palermo M Nevitt RS Valentin D Black SR Cummings (1996) ArticleTitleComparison of semiquantitative visual and quantitative morphometric assessment of prevalent and incident vertebral fractures in osteoporosis. The Study of Osteoporotic Fractures Research Group J Bone Miner Res 11 984–996 Occurrence Handle1:STN:280:BymA1M%2Fgt1I%3D Occurrence Handle8797120

    CAS  PubMed  Google Scholar 

  22. M Fukunaga T Nakamura M Shiraki T Kuroda H Ohta T Hosoi H Orimo (2004) ArticleTitleAbsolute height reduction and percent height ratio of the vertebral body in incident fracture in Japanese women J Bone Miner Metab 22 104–110 Occurrence Handle10.1007/s00774-003-0457-z Occurrence Handle14999520

    Article  PubMed  Google Scholar 

  23. DA Shoenfeld (1983) ArticleTitleSample-size formula for the proportional-hazards regression model Biometrika 39 499–503

    Google Scholar 

  24. MR McClung P Geusens PD Miller H Zippel WG Bensen C Roux S Adami I Fogelman T Diamond R Eastell PJ Meunier JY Reginster (2001) ArticleTitleEffect of risedronate on the risk of hip fracture in elderly women. HIP Intervention Program Study Group N Engl J Med 344 333–340 Occurrence Handle10.1056/NEJM200102013440503 Occurrence Handle1:CAS:528:DC%2BD3MXht1Wlu7g%3D Occurrence Handle11172164

    Article  CAS  PubMed  Google Scholar 

  25. CM Klotzbuecher PD Ross PB Landsman TA Abbott Suffix3rd M Berger (2000) ArticleTitlePatients with prior fractures have an increased risk of future fractures: a summary of the literature and statistical synthesis J Bone Miner Res 15 721–739 Occurrence Handle1:STN:280:DC%2BD3c3ktFOktA%3D%3D Occurrence Handle10780864

    CAS  PubMed  Google Scholar 

  26. PD Ross HK Genant JW Davis PD Miller RD Wasnich (1993) ArticleTitlePredicting vertebral fracture incidence from prevalent fractures and bone density among non-black, osteoporotic women Osteoporos Int 3 120–126 Occurrence Handle10.1007/BF01623272 Occurrence Handle1:STN:280:ByyB2cvlt10%3D Occurrence Handle8481587

    Article  CAS  PubMed  Google Scholar 

  27. P Lips (1997) ArticleTitleEpidemiology and predictors of fractures associated with osteoporosis Am J Med 103 3S–11S Occurrence Handle10.1016/S0002-9343(97)90021-8 Occurrence Handle1:STN:280:ByiH2cfls1I%3D Occurrence Handle9302892

    Article  CAS  PubMed  Google Scholar 

  28. DK Roy TW O'Neill JD Finn M Lunt AJ Silman et al. (2003) ArticleTitleDeterminants of incident vertebral fracture in men and women: results from the European Prospective Osteoporosis Study (EPOS) Osteoporos Int 14 19–26 Occurrence Handle10.1007/s00198-002-1317-8 Occurrence Handle1:STN:280:DC%2BD3s%2Fms1Orug%3D%3D Occurrence Handle12577181

    Article  CAS  PubMed  Google Scholar 

  29. P Garnero E Hausherr MC Chapuy C Marcelli H Grandjean C Muller C Cormier G Breart PJ Meunier PD Delmas (1996) ArticleTitleMarkers of bone resorption predict hip fracture in elderly women: the EPIDOS Prospective Study J Bone Miner Res 11 1531–1538 Occurrence Handle1:STN:280:ByiD2cvnvVc%3D Occurrence Handle8889854

    CAS  PubMed  Google Scholar 

  30. PL van Daele MJ Seibel H Burger A Hofman DE Grobbee JP Van Leeuwen JC Brikenhager HA Pols (1996) ArticleTitleCase-control analysis of bone resorption markers, disability, and hip fracture risk: the Rotterdam study BMJ 312 482–483 Occurrence Handle1:STN:280:BymC2srps1M%3D Occurrence Handle8597681

    CAS  PubMed  Google Scholar 

  31. HW Woitge MJ Seibel (2000) ArticleTitleRisk assessment for osteoporosis. II. Biochemical markers of bone turnover: bone resorption indices Clin Lab Med 20 503–525 Occurrence Handle1:STN:280:DC%2BD3M%2FmsVSltQ%3D%3D Occurrence Handle10986618

    CAS  PubMed  Google Scholar 

  32. P Garnero E Sornay-Rendu B Claustrat PD Delmas (2000) ArticleTitleBiochemical markers of bone turnover, endogenous hormones and the risk of fractures in postmenopausal women: the OFELY study J Bone Miner Res 15 1526–1536 Occurrence Handle1:CAS:528:DC%2BD3cXlvVSjtrg%3D Occurrence Handle10934651

    CAS  PubMed  Google Scholar 

  33. PD Delmas L van de Langerijt NB Watts R Eastell H Genant A Grauer DL Cahall InstitutionalAuthorNameIMPACT Study Group (2005) ArticleTitleUnderdiagnosis of vertebral fractures is a worldwide problem: the IMPACT study J Bone Miner Res 20 557–563 Occurrence Handle15765173

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Research Institute and Practice for Involutional Diseases, 1610-1 Meisei, Misato, Azumino, 399-8101, Japan

    Masataka Shiraki

  2. Public Health Research Foundation, Tokyo, Japan

    Tatsuhiko Kuroda

  3. Department of Orthopedic Surgery, University of Occupational and Environmental Health, Fukuoka, Japan

    Toshitaka Nakamura

  4. Department of Nuclear Medicine, Kawasaki Medical School, Okayama, Japan

    Masao Fukunaga

  5. Department of Endocrinology and Metabolism, Tokyo Metropolitan Geriatric Medical Center, Tokyo, Japan

    Takayuki Hosoi

  6. Health Science University, Yamanashi, Japan

    Hajime Orimo

  7. Tokyo Metropolitan Research Laboratory of Public Health, Tokyo, Japan

    Kuniyoshi Makino

Authors
  1. Masataka Shiraki
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Tatsuhiko Kuroda
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Toshitaka Nakamura
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Masao Fukunaga
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Takayuki Hosoi
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Hajime Orimo
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Kuniyoshi Makino
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Masataka Shiraki.

About this article

Cite this article

Shiraki, M., Kuroda, T., Nakamura, T. et al. The sample size required for intervention studies on fracture prevention can be decreased by using a bone resorption marker in the inclusion criteria: prospective study of a subset of the Nagano Cohort, on behalf of the Adequate Treatment of Osteoporosis (A-TOP) Research Group. J Bone Miner Metab 24, 219–225 (2006). https://doi.org/10.1007/s00774-005-0675-7

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00774-005-0675-7

Key words

Search

Navigation